HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perioperative epidural analgesia and outcome after major abdominal surgery in high-risk patients.

Abstract
In a primary analysis of a large recently completed randomized trial in 915 high-risk patients undergoing major abdominal surgery, we found no difference in outcome between patients receiving perioperative epidural analgesia and those receiving IV opioids, apart from the incidence of respiratory failure. Therefore, we performed a selected number of predetermined subgroup analyses to identify specific types of patients who may have derived benefit from epidural analgesia. We found no difference in outcome between epidural and control groups in subgroups at increased risk of respiratory or cardiac complications or undergoing aortic surgery, nor in a subgroup with failed epidural block (all P > 0.05). There was a small reduction in the duration of postoperative ventilation (geometric mean [SD]: control group, 0.3 [6.5] h, versus epidural group, 0.2 [4.8] h; P = 0.048). No differences were found in length of stay in intensive care or in the hospital. There was no relationship between frequency of use of epidural analgesia in routine practice outside the trial and benefit from epidural analgesia in the trial. We found no evidence that perioperative epidural analgesia significantly influences major morbidity or mortality after major abdominal surgery.
AuthorsPhilip J Peyton, Paul S Myles, Brendan S Silbert, John A Rigg, Konrad Jamrozik, Richard Parsons
JournalAnesthesia and analgesia (Anesth Analg) Vol. 96 Issue 2 Pg. 548-, table of contents (Feb 2003) ISSN: 0003-2999 [Print] United States
PMID12538211 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Opioid
Topics
  • Abdomen (surgery)
  • Analgesia, Epidural (adverse effects)
  • Analgesics, Opioid (administration & dosage, therapeutic use)
  • Aorta, Abdominal (surgery)
  • Critical Care
  • Endpoint Determination
  • Heart Diseases (complications)
  • Humans
  • Injections, Intravenous
  • Length of Stay
  • Respiratory Insufficiency (chemically induced)
  • Risk Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: